[Measurements of survival in the evaluation of a treatment. The cardiologist and the large clinical trials of coronary thrombolysis].
Since late eighties, large clinical trials on thrombolytic therapy have introduced in cardiology literature the use of survival measures in order to assess the consequences of treatment. In this article a systematic review of the more frequently adopted measures is presented, together with the proposal of other measures, more useful for the clinician.
Zanolla
L
L
Cattedra E Divisione Clinicizzata di Cardiologia, Università di Verona.
Marubini
E
E
D002986:Clinical Trials as Topic; D005500:Follow-Up Studies; D006760:Hospitalization; D006801:Humans; D015233:Models, Statistical; D009203:Myocardial Infarction / Q000401:mortality* / Q000628:therapy*; D011336:Probability; D015912:Thrombolytic Therapy; D013997:Time Factors
Misure di sopravvivenza per valutare l'effetto di un trattamento. Il cardiologo di fronte alle grandi sperimentazioni cliniche sulla trombolisi coronarica.